According to Nice the inclusive term 'greater trochanteric pain syndrome' is preferred as the trochanteric bursae play a smaller role than was previously thought and inflammation is not always present. Recent evidence now suggests it is primarily caused by pathology of the gluteal tendons, particularly gluteus medius and minimus. Gluteal tendinopathy can be associated with trochanteric bursal ‘distension’ but research does not support the presence of an inflammatory bursitis. Isolated bursal pathology is rare and if present is
almost always associated with a tendinopathy.
In a study by Reid 20151, the annual incidence of trochanteric pain was reported as being 1.8-5.6/1000. More common in women than men with a ratio of 4:1 and increased prevalence in 40-60 age group Chowdhury et al 20142- hypothetically is this due to menopausal changes and weakness in core muscle groups.
Corticosteroid injections are not recommended as treatment for trochanteric bursitis within primary care or secondary care.
References:-
- Reid D. The management of greater trochanteric pain syndrome: A systematic literature review. J Orthop. 2016 Jan 22;13(1):15-28. doi: 10.1016/j.jor.2015.12.006. PMID: 26955229; PMCID: PMC4761624.
- Chowdhury R, Naaseri S, Lee J, Rajeswaran G. Imaging and management of greater trochanteric pain syndrome. Postgrad Med J. 2014 Oct;90(1068):576-81. doi: 10.1136/postgradmedj-2013-131828. Epub 2014 Sep 3. PMID: 25187570.